利润表
ATARA BIOTHERAPEUTICS, INC.
ATRA
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业费用
|
63.70 | 191.37 | 275.69 | 344.09 | 360.80 | 309.05 | 295.68 | 237.11 | 121.53 | 81.24 | 58.45 | 28.16 |
|
研发费用
|
37.45 | 151.48 | 224.79 | 272.53 | 282.00 | 244.65 | 216.10 | 167.46 | 81.21 | 56.51 | - | 14.38 |
|
销售、一般及行政费用
|
26.25 | 39.89 | 50.91 | 71.55 | 78.80 | 64.40 | 79.58 | 69.65 | 40.33 | 24.73 | 16.83 | 12.71 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-63.70 | -191.37 | -275.69 | -344.09 | -360.80 | -309.05 | -295.68 | -237.11 | -121.53 | -81.24 | -58.45 | -28.16 |
|
营业外收入
|
-96.42 | -105.95 | 0.42 | -115.80 | -20.71 | -2.45 | -4.72 | -6.37 | -2.03 | -2.20 | -1.22 | -0.13 |
|
利息收入
|
0.68 | 2.11 | 5.43 | - | - | - | - | - | - | - | - | 0.13 |
|
利息支出
|
3.79 | 4.62 | 5.29 | - | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
-0.03 | 0.53 | -0.25 | 1.99 | 0.37 | 2.45 | 4.72 | 6.37 | 2.03 | 2.20 | 1.22 | - |
|
税前利润
|
32.72 | -85.42 | -276.11 | -228.29 | -340.10 | -306.61 | -290.96 | -230.74 | -119.51 | -79.04 | -57.23 | -28.03 |
|
所得税费用
|
0.03 | -0.01 | 0.02 | 0.01 | 0.05 | 0.02 | 0.01 | -0.04 | -0.01 | 0.01 | -0.01 | -0.03 |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
32.69 | -85.40 | -276.13 | -228.30 | -340.14 | -306.62 | -290.98 | -230.70 | -119.49 | -79.05 | -57.22 | -28.01 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-61.58 | -186.32 | -270.86 | -338.39 | -351.46 | -300.72 | -288.58 | -233.38 | -120.58 | -81.24 | -58.45 | -28.16 |
|
基本每股收益
|
2.61 | -11.41 | -2.61 | -2.24 | - | - | - | - | - | - | - | - |
|
稀释每股收益
|
2.57 | -11.41 | -2.61 | -2.24 | - | - | - | - | - | - | - | - |
|
加权平均股数
|
12.54 | 7.49 | 105.91 | 101.99 | - | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
12.72 | 7.49 | 105.91 | 101.99 | - | - | - | - | - | - | - | - |
|
综合收益
|
32.68 | -85.19 | -274.26 | -230.00 | -340.81 | -306.54 | -290.42 | -230.89 | -119.46 | -78.71 | -57.64 | - |